The Global Drug Market for Dermatological Conditions Associated with Ageing and Lifestyle Was Estimated at US$1.8 Billion in 2005.

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c28592) has announced the addition of Spectra Intelligence's The Global Image Dermatology Drug Market, 2005-2012: High-Growth Opportunities in Aesthetic Medicine to their offering.

Examines the global market for aesthetic dermatologicals and specialty physician-dispensed drugs to treat conditions associated with deficits in physical image and form. Drugs such as botulinum toxins, retinoids, acid peels, 5-alpha reductase and lipase inhibitors associated with cutaneous ageing, photodamage, pigmentation defects, alopecia, and the lipodermal disorders of obesity and gynoid lipodystrophy are critically discussed to provide a detailed analysis of the high-growth market sector estimated at US$1.8 billion in 2005 and forecast to increase by 114% to US$3.9 billion by 2012. The report includes insights for product extension and optimization, sales forecasts to 2012, and impact of late-stage pipeline drugs on the market. Therapy area forecasting and illustrative market data and analysis is also presented to gain insight into top-performing products and therapy areas.

Objectives of the Report Briefing The objectives of this report are to provide a detailed analysis of the global image dermatology drug market. Included in this study are analyses of key therapy areas, R&D programs, and innovating companies and products. The report briefing also aims to expand knowledge of the therapeutic areas and to highlight the role of antiageing medicines and lifestyle drugs in an increasingly ageing world population. It is hoped that the reader will benefit from market forecasts, pooled knowledge of recent industrial activities and events, and from analytical discourse, which is intended to stimulate growth and create new market opportunities.

Research Methodology The contents of this report are derived from in-depth research-based surveys of the industry; communication with senior corporate executives; and proprietary analytical assessment tools.

Source material also comprises the following: - Company information - Personal communication - Trade press articles - News releases - Internet-based research - Library research - Scientific periodicals - Product information - Market analyst data - Public information datasets - Conference proceedings - Medical/pharma associations

Please note this report is delivered in pdf format which cannot be printed. For further information on ordering a pdf version which can be printed, please click enquire before buying

Topics Covered
List of Tables
List of Figures
Executive Summary
Chapter 1 Introduction to Antiageing and Image Dermatology
Chapter 2 Image Dermatology Drug Markets
Chapter 3 Drugs in Research and Development
Chapter 4 Market Analysis, Therapy Forecasting, and Prospect Mining
Chapter 5 Report Synopsis

Summary Image dermatology is a high-growth market opportunity based on the increasing numbers of people turning to medical and surgical intervention to combat signs of cutaneous ageing and to correct perceived deficits in physical form.

Demand for therapeutic dermatologicals to treat conditions such as alopecia, cutaneous ageing, photodamage, skin pigmentation, and the lipodermal disorders of obesity and gynoid lipodystrophy (cellulite) will be driven by factors such as increasing worldwide ageing populations; unrelenting media fixation on physical improvement and restorative antiageing treatments; and innovation in the pharmaceutical industry to bring to market highly sophisticated efficacious drug treatments that serve to close the gap between medical and cosmetic interventions.

The global drug market for dermatological conditions associated with ageing and lifestyle is estimated at US$1.8 billion in 2005 and is forecast to increase by 114% to US$3.9 billion by 2012. In this report, The Global Image Dermatology Drug Market, 2005-2012: High-Growth Opportunities in Aesthetic Medicine, the reader will be introduced to a specialty pharmaceutical therapy area that is poised for significant expansion based on new pharmacotherapies to address cutaneous ageing, pigmentation disorders, obesity and gynoid lipodystrophy.

The report provides a detailed analysis of the sector to include insights for product extension and optimization, sales forecasts to 2012, and impact of late-stage pipeline drugs on the market. Each therapy area segment concludes with a summary of the key issues that are considered to affect growth and sustainability. An overview of R&D programs within the field is also highlighted showing products from preclinical to premarket authorization phases of development. Promising agents are discussed in relation to development status and commercial prospects.

Therapy area forecasting and illustrative market data and analysis are also presented to provide an insight into top-performing products and sales estimates to 2012. Therapy forecasting to 2020 is also detailed to enable the reader to make key assumptions about future markets and prospects, and utilize the data for proprietary predictive market modeling.

For more information visit http://www.researchandmarkets.com/reports/c28592